We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Risk-Based AI Algorithm Detects Cancer from Limited Number of Mammograms

By MedImaging International staff writers
Posted on 01 Apr 2021
Illustration
Illustration
A risk-based algorithm - based on clinical indication, breast symptoms, breast cancer history, and age – was found to successfully maximize cancer detection from limited mammograms.

In a unique study, researchers at the Kaiser Permanente Washington Health Research Institute (KPWHRI; Seattle, WA, USA) have found a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19. In one of the largest studies of its kind, the researchers looked at nearly 900,000 individuals and close to two million mammograms from 2014 to 2019 at more than 90 radiology facilities in the national Breast Cancer Surveillance Consortium.

They found that a risk-based algorithm - based on clinical indication, breast symptoms, breast cancer history, and age - successfully maximized cancer detection. The results showed that 12% of mammograms with “very high” and “high” cancer detection rates accounted for 55% of detected cancers, while 44% of mammograms with “very low” cancer detection rates accounted for 13% of detected cancers.

“What this means is that triaging individuals most likely to have cancer during periods of reduced capacity may be effective at detecting the most cancers with the fewest mammograms versus using a non-risk-based approach,” said Diana L. Miglioretti, professor and division chief of biostatistics at the UC Davis Department of Public Health Sciences and affiliate investigator with KPWHRI who led the study. “Whether it is due to unexpected new surges in COVID-19 cases prompting new lockdowns or other emergencies such as cyberattacks or natural disasters like wildfires, the study results provide important guidance for navigating through any crisis that could impact the availability of mammograms.”

Related Links:
Kaiser Permanente Washington Health Research Institute

Digital Radiographic System
OMNERA 300M
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Portable X-ray Unit
AJEX140H

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.